Growth Metrics

Arcadia Biosciences (RKDA) Equity Income (2022)

Arcadia Biosciences' Equity Income history spans 2 years, with the latest figure at $1.1 million for Q2 2022.

  • For Q2 2022, Equity Income changed N/A year-over-year to $1.1 million; the TTM value through Jun 2023 reached $1.1 million, changed 0.0%, while the annual FY2022 figure was $1.1 million, N/A changed from the prior year.
  • Equity Income reached $1.1 million in Q2 2022 per RKDA's latest filing, up from -$536000.0 in the prior quarter.
  • In the past five years, Equity Income ranged from a high of $1.1 million in Q2 2022 to a low of $1.1 million in Q2 2022.